• Issue

    British Journal of Haematology: Volume 187, Issue 3

    265-403, e58-e82
    November 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information

  • Pages: 265-272
  • First Published: 28 October 2019

Images in Haematology

Late presentation of dyskeratosis congenita

William Shomali,  Rondeep Brar, 
  • Page: 273
  • First Published: 05 August 2019

Clofarabine-induced bluish discolouration of teeth

Divya Doval,  Sanjeev K. Sharma,  Dharma Choudhary,  Meet Kumar,  Vipin Khandelwal, 
  • Page: 274
  • First Published: 05 August 2019

Editorial Comments

“Fine-tuning cytoreduction in resistant multiple myeloma - progress here, too”?

Torben Plesner, 
  • Pages: 275-276
  • First Published: 19 June 2019

Reviews

How we manage Bing–Neel syndrome

Jorge J. Castillo,  Steven P. Treon, 
  • Pages: 277-285
  • First Published: 20 August 2019

A journey through infectious risk associated with ruxolitinib

Emanuela Sant’Antonio,  Massimiliano Bonifacio,  Massimo Breccia,  Elisa Rumi, 
  • Pages: 286-295
  • First Published: 29 August 2019

Guideline

Free Access

Point of care testing in general haematology

Ciaran Mooney,  Mary Byrne,  Patience Kapuya,  Lorna Pentony,  Barbara De la Salle,  Tony Cambridge,  David Foley,  on behalf of the British Society for Haematology Guideline , 
  • Pages: 296-306
  • First Published: 02 October 2019

Haematological Malignancy

Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients

Boyu Hu,  Keyur P. Patel,  Hsiang-Chun Chen,  Xuemei Wang,  Rajyalakshmi Luthra,  Mark J. Routbort,  Rashmi Kanagal-Shamanna,  L. Jeffrey Medeiros,  C. Cameron Yin,  Zhuang Zuo,  Chi Y. Ok,  Sanam Loghavi,  Guilin Tang,  Francesco P. Tambaro,  Philip Thompson,  Jan Burger,  Nitin Jain,  Alessandra Ferrajoli,  Prithviraj Bose,  Zeev Estrov,  Michael Keating,  William G. Wierda, 
  • Pages: 307-318
  • First Published: 26 June 2019

Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial

Eileen M. Boyle,  Xavier Leleu,  Marie-Odile Petillon,  Lionel Karlin,  Chantal Doyen,  Hélène Demarquette,  Bruno Royer,  Margaret Macro,  Philippe Moreau,  Karel Fostier,  Chretien Marie-Lorraine,  Charles Zarnitsky,  Aurore Perrot,  Charles Herbaux,  Stephanie Poulain,  Salomon Manier,  David Beauvais,  Brian A. Walker,  Christopher P. Wardell,  Laure Vincent,  Laurent Frenzel,  Hélène Caillon,  Schraen Susanna,  Thomas Dejoie,  Hervé Avet-Loiseau,  Mohamad Mohty,  Thierry Facon, On behalf of the IFM2014-04 investigators , 
  • Pages: 319-327
  • First Published: 19 June 2019
Open Access

Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years

Kosei Matsue,  Yoshiaki Abe,  Kentaro Narita,  Hiroki Kobayashi,  Akihiro Kitadate,  Masami Takeuchi,  Daisuke Miura,  Kengo Takeuchi, 
  • Pages: 328-336
  • First Published: 03 July 2019

Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome

Marc G. Berger,  Bruno Pereira,  Philippe Rousselot,  Pascale Cony-Makhoul,  Martine Gardembas,  Laurence Legros,  Martine Escoffre-Barbe,  Franck-Emmanuel Nicolini,  Sandrine Saugues,  Céline Lambert,  Delphine Réa,  Agnès Guerci-Bresler,  Stéphane Giraudier,  Joëlle Guilhot,  Susanne Saussele,  François-Xavier Mahon, On behalf of the (France Intergroupe des Leucémies Myéloïdes Chroniques) , 
  • Pages: 337-346
  • First Published: 04 July 2019

Rituximab-PECC induction followed by 90Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study

Pieternella J. Lugtenburg,  Josee M. Zijlstra,  Jeanette K. Doorduijn,  Lara H. Böhmer,  Mels Hoogendoorn,  Henriette W. Berenschot,  Aart Beeker,  Nicole C. van der Burg-de Graauw,  Harry C. Schouten,  Yavuz M. Bilgin,  Marie-Jose Kersten,  Harry R. Koene,  Alexandra H. E. Herbers,  Daphne de Jong,  Nathalie Hijmering,  King H. Lam,  Dana Chiţu,  Rolf E. Brouwer,  Gustaaf W. van Imhoff, for the Dutch HOVON group , 
  • Pages: 347-355
  • First Published: 10 July 2019

CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib

Jorge J. Castillo,  Lian Xu,  Joshua N. Gustine,  Andrew Keezer,  Kirsten Meid,  Toni E. Dubeau,  Xia Liu,  Maria G. Demos,  Amanda Kofides,  Nicholas Tsakmaklis,  Jiaji G. Chen,  Manit Munshi,  Maria L. Guerrera,  Gloria G. Chan,  Christopher J. Patterson,  Guang Yang,  Zachary R. Hunter,  Steven P. Treon, 
  • Pages: 356-363
  • First Published: 03 July 2019

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era

Roosa E. I. Prusila,  Marc Sorigue,  Jyrki Jauhiainen,  Santiago Mercadal,  Aleksi Postila,  Petteri Salmi,  Taru Tanhua,  Susanna Tikkanen,  Sakari Kakko,  Hanne Kuitunen,  Marjukka Pollari,  Ilja Nystrand,  Milla E. L. Kuusisto,  Kaija Vasala,  Esa Jantunen,  Eija Korkeila,  Peeter Karihtala,  Juan-Manuel Sancho,  Taina Turpeenniemi-Hujanen,  Outi Kuittinen, 
  • Pages: 364-371
  • First Published: 03 July 2019

Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1–positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study

Kenichi Sakamoto,  Norio Shiba,  Takao Deguchi,  Nobutaka Kiyokawa,  Yoshiko Hashii,  Akiko Moriya-Saito,  Daisuke Tomizawa,  Takashi Taga,  Soichi Adachi,  Keizo Horibe,  Toshihiko Imamura, 
  • Pages: 372-376
  • First Published: 27 June 2019

A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove

Sally Cox-Morton,  Stephen MacDonald,  Will Thomas, 
  • Pages: 377-385
  • First Published: 10 July 2019

Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane

Oliver Andres,  Felicia Loewecke,  Henner Morbach,  Sabrina Kraus,  Hermann Einsele,  Stefan Eber,  Christian P. Speer, 
  • Pages: 386-395
  • First Published: 05 July 2019

Correspondence

Free Access

Value of detecting bone marrow involvement in Hodgkin lymphoma - Response to Adams and Kwee

Mette A. Pedersen,  Lars C. Gormsen,  Francesco d'Amore, 
  • Pages: 396-397
  • First Published: 04 September 2019
Free Access

Value of detecting bone marrow involvement in Hodgkin lymphoma

Hugo J.A. Adams,  Thomas C. Kwee, 
  • Pages: 397-399
  • First Published: 16 September 2019
Free Access

Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib

Elizabeth M. Kander,  Qiuhong Zhao,  Seema A. Bhat,  Jessica Hirsch,  John C. Byrd,  Lauren Ooka,  Tracy Wiczer,  Jennifer A. Woyach,  Farrukh T. Awan,  Kerry A. Rogers,  Tzu-Fei Wang, 
  • Pages: 399-402
  • First Published: 18 September 2019

Book Reviews

Haematology in Critical Care: A Practical Handbook

Barbara J. Bain, 
  • Page: 403
  • First Published: 28 October 2019

Blood Cells: Morphology and Clinical Relevance

Barbara J. Bain, 
  • Page: 403
  • First Published: 28 October 2019

Correspondence

Free Access

Detection by a simple and cheaper methodology of Ik6 and Ik10 isoforms of the IKZF1 gene is highly associated with a poor prognosis in B-lineage paediatric acute lymphoblastic leukaemia

Larissa B. P. Moreira,  Rosane de P. Queiróz,  Veridiana K. Suazo,  Elisabeth Perna,  Silvia R. Brandalise,  José A. Yunes,  Luiz G. Tone,  Carlos A. Scrideli, 
  • Pages: e58-e61
  • First Published: 04 September 2019
Free Access

Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet count

Hanny Al-Samkari,  David J. Kuter, 
  • Pages: e61-e64
  • First Published: 05 September 2019
Free Access

Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation

Razan Mohty,  Eolia Brissot,  Giorgia Battipaglia,  Annalisa Ruggeri,  Rémy Dulery,  Agnès Bonnin,  Clémence Médiavilla,  Simona Sestili,  Ramdane Belhocine,  Anne Vekhoff,  Tounes Ledraa,  Camelia Simona Lapusan,  Rosa Adaeva,  Françoise Isnard,  Olivier Legrand,  Mohamad Mohty,  Florent Malard, 
  • Pages: e64-e68
  • First Published: 05 September 2019
Free Access

Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms

Sebastian Francis,  Sally Thomas,  Robert Luben,  Nikolaos Sousos,  Adam Mead,  John A. Snowden,  Martin P. Zeidler, 
  • Pages: e69-e72
  • First Published: 16 September 2019
Free Access

A novel Haemato-oncology Frailty (HOF) score tool predicts survival in over 80s with Multiple Myeloma

Richard Hinton,  Shuli Levy,  Richard Szydlo,  Simona Deplano, 
  • Pages: e72-e75
  • First Published: 13 September 2019
Free Access

Novel three-way fusions among ZNF384, EWSR1 and EHMT1 genes in paediatric B cell precursor acute lymphoblastic leukaemia with translocations resembling Philadelphia chromosomes

Xue Chen,  Fang Wang,  Panxiang Cao,  Yang Zhang,  Xiaoli Ma,  Mingyue Liu,  Wen Teng,  Junfang Yang,  Jianping Zhang,  Tong Wang,  Hongxing Liu, 
  • Pages: e75-e79
  • First Published: 18 September 2019
Free Access

Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type

Cosimo Di Raimondo,  Farah R. Abdulla,  Jasmine Zain,  Christiane Querfeld,  Steven T. Rosen, 
  • Pages: e79-e82
  • First Published: 30 September 2019